{"id":"3818e213-4a12-5df9-9fae-d2d5a8bcbadb","stable_key":"f2ec2007-88ff-5a96-a73b-8b5085e9cea9:mbz-adds-to-radiation","predicate":"increases","statement":"In meningioma cell lines the half-maximal inhibitory concentration for mebendazole was 0.26 to 0.42 micromolar, mebendazole alone induced cytotoxicity but the combination with radiation gave a greater reduction in colony formation and higher levels of cleaved caspase-3, and in mice implanted intracranially with human meningioma both mebendazole alone and the combination gave a survival benefit with increased apoptosis and decreased tumour cell and vascular proliferation.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"6056728e-33c2-5183-9ace-44bf8814d9be","mechanism_event_label":"Added to radiation it killed more tumour cells than radiation alone.","subject":{"id":"f8582a13-fc2e-5127-a61f-5b0594e54069","slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"},"object":{"id":"c9a7347b-9fb4-5e29-922c-c532789388f4","slug":"radiotherapy","display_name":"Radiotherapy","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"6056728e-33c2-5183-9ace-44bf8814d9be","stable_key":"f2ec2007-88ff-5a96-a73b-8b5085e9cea9:mbz-adds-to-radiation-event","event_type":"biochemical_relationship","label":"Added to radiation it killed more tumour cells than radiation alone.","description":"In meningioma cell lines the half-maximal inhibitory concentration for mebendazole was 0.26 to 0.42 micromolar, mebendazole alone induced cytotoxicity but the combination with radiation gave a greater reduction in colony formation and higher levels of cleaved caspase-3, and in mice implanted intracranially with human meningioma both mebendazole alone and the combination gave a survival benefit with increased apoptosis and decreased tumour cell and vascular proliferation.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"d8d37840-da4f-5060-8466-307f79cfd133","slug":"meningioma-cell-viability","display_name":"Viability of malignant meningioma cells","entity_type_key":"cellular_process"},"role":"affected_process","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"346790f2-c292-5dcf-8266-2332c41c7c38","slug":"casp3","display_name":"Human caspase-3 / CASP3","entity_type_key":"protein"},"role":"activated_enzyme","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"e771d86a-d95b-520c-a3eb-2f81733eee5d","slug":"tumour-angiogenesis","display_name":"Tumour angiogenesis, as distinguished from normal brain vasculature","entity_type_key":"cellular_process"},"role":"reduced_process","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"f8582a13-fc2e-5127-a61f-5b0594e54069","slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"c9a7347b-9fb4-5e29-922c-c532789388f4","slug":"radiotherapy","display_name":"Radiotherapy","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/mebendazole-research/30414098.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"34445c01e56a2bfa33e4d1118f86c291fab041b15fa08da37592f4ec92d81400\", \"start_char\": 0, \"end_char\": 1743, \"text_sha256\": \"34445c01e56a2bfa33e4d1118f86c291fab041b15fa08da37592f4ec92d81400\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Colony formation, proliferation and caspase assays with intracranial human meningioma implants in mice","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Mebendazole alone and combined with radiation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A combination study in one meningioma line and one implanted model. The mechanism is inferred from immunohistochemistry rather than dissected.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms.","comparator":null,"unit":null,"notes":"","entity":{"slug":"mebendazole","display_name":"Mebendazole","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human cells and mouse","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Added to radiation it killed more tumour cells than radiation alone.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[mbz-p30414098] Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma. (2018). https://pubmed.ncbi.nlm.nih.gov/30414098/ DOI: 10.1007/s11060-018-03009-7","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Malignant meningioma","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"ef9a7911-a064-59a2-97af-e5715bfbb4e1","evidence_kind":"source_excerpt","locator":"Lines 563-574","start_line":563,"end_line":574,"excerpt":"### mbz-adds-to-radiation\nIn meningioma cell lines the half-maximal inhibitory concentration for mebendazole was 0.26 to 0.42 micromolar, mebendazole alone induced cytotoxicity but the combination with radiation gave a greater reduction in colony formation and higher levels of cleaved caspase-3, and in mice implanted intracranially with human meningioma both mebendazole alone and the combination gave a survival benefit with increased apoptosis and decreased tumour cell and vascular proliferation.\nCondition category: normal\nnutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms.\nplain_language: Added to radiation it killed more tumour cells than radiation alone.\norganism: Human cells and mouse\ntissue_or_cell_type: Malignant meningioma\nexperimental_model: Colony formation, proliferation and caspase assays with intracranial human meningioma implants in mice\nlimitations: A combination study in one meningioma line and one implanted model. The mechanism is inferred from immunohistochemistry rather than dissected.\nexposure: Mebendazole alone and combined with radiation\nevidence_span: {\"source_cache\": \"artifacts/mebendazole-research/30414098.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"34445c01e56a2bfa33e4d1118f86c291fab041b15fa08da37592f4ec92d81400\", \"start_char\": 0, \"end_char\": 1743, \"text_sha256\": \"34445c01e56a2bfa33e4d1118f86c291fab041b15fa08da37592f4ec92d81400\"}\n[mbz-p30414098] Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma. (2018). https://pubmed.ncbi.nlm.nih.gov/30414098/ DOI: 10.1007/s11060-018-03009-7","model_system":"Colony formation, proliferation and caspase assays with intracranial human meningioma implants in mice","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [mbz-p30414098] Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma. (2018). https://pubmed.ncbi.nlm.nih.gov/30414098/ DOI: 10.1007/s11060-018-03009-7","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"06104773-03d0-5e5c-b9da-eb484e7be657","stable_key":"import-f2ec2007-88ff-5a96-a73b-8b5085e9cea9","title":"Mebendazole: the tubulin it binds, why that is selective, the crystal form that decides whether any of it works, and the off-target that became an oncology programme (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"58b652636677e5033fd1dd555744485fcef18f21a97dcf68723fe072b656f413","revision_id":"a2cd9c22-0549-52ca-a653-8a0c2362ec85","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}